mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for AHCYL1
Gene summary
Basic gene Info.Gene symbolAHCYL1
Gene nameadenosylhomocysteinase-like 1
SynonymsDCAL|IRBIT|PPP1R78|PRO0233|XPVKONA
CytomapUCSC genome browser: 1p13.2
Type of geneprotein-coding
RefGenesNM_001242673.1,
NM_001242674.1,NM_001242675.1,NM_001242676.1,NM_006621.5,
DescriptionDC-expressed AHCY-like moleculeS-adenosyl homocysteine hydrolase homologS-adenosyl-L-homocysteine hydrolase 2S-adenosylhomocysteine hydrolase-like protein 1adoHcyase 2dendritic cell expressed AHCY-like proteininositol 1,4,5-trisphosphate receptor-bi
Modification date20141207
dbXrefs MIM : 607826
HGNC : HGNC
Ensembl : ENSG00000168710
HPRD : 07613
Vega : OTTHUMG00000011652
ProteinUniProt: O43865
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_AHCYL1
BioGPS: 10768
PathwayNCI Pathway Interaction Database: AHCYL1
KEGG: AHCYL1
REACTOME: AHCYL1
Pathway Commons: AHCYL1
ContextiHOP: AHCYL1
ligand binding site mutation search in PubMed: AHCYL1
UCL Cancer Institute: AHCYL1
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for AHCYL1

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
H399S400PSTAD1
C292R294QUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for AHCYL1
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
H399S400P0.033208971
C292R294Q-0.71976929
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for AHCYL1 from PDB

Top
Differential gene expression and gene-gene network for AHCYL1
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of AHCYL1 and the right PPI network was created from samples without mutations in the LBS of AHCYL1. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for AHCYL1
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for AHCYL1
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of AHCYL1 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NADNAD ZWITTERION3mtgAC292 H399
NADNAD ZWITTERION3mtgBC292 H399


Top
Conservation information for LBS of AHCYL1
Multiple alignments for O43865 in multiple species
LBSAA sequence# speciesSpecies
C292FDNLYCCRESI3Homo sapiens, Mus musculus, Rattus norvegicus
C346EIDPICALQAC3Homo sapiens, Mus musculus, Rattus norvegicus
C373DVVITCTGNKN3Homo sapiens, Mus musculus, Rattus norvegicus
D343YITEIDPICAL3Homo sapiens, Mus musculus, Rattus norvegicus
E321VCGYGEVGKGC3Homo sapiens, Mus musculus, Rattus norvegicus
E341IVYITEIDPIC3Homo sapiens, Mus musculus, Rattus norvegicus
G318QVVVCGYGEVG3Homo sapiens, Mus musculus, Rattus norvegicus
G320VVCGYGEVGKG3Homo sapiens, Mus musculus, Rattus norvegicus
G375VITCTGNKNVV3Homo sapiens, Mus musculus, Rattus norvegicus
G398IVCNMGHSNTE3Homo sapiens, Mus musculus, Rattus norvegicus
H399VCNMGHSNTEI3Homo sapiens, Mus musculus, Rattus norvegicus
I342VYITEIDPICA3Homo sapiens, Mus musculus, Rattus norvegicus
K524KNGPFKPNYYR3Homo sapiens, Mus musculus, Rattus norvegicus
L442LAEGRLLNLSC3Homo sapiens, Mus musculus, Rattus norvegicus
M397CIVCNMGHSNT3Homo sapiens, Mus musculus, Rattus norvegicus
N376ITCTGNKNVVT3Homo sapiens, Mus musculus, Rattus norvegicus
Q511ELTDDQAKYLG3Homo sapiens, Mus musculus, Rattus norvegicus
T340AIVYITEIDPI3Homo sapiens, Mus musculus, Rattus norvegicus
T374VVITCTGNKNV3Homo sapiens, Mus musculus, Rattus norvegicus
V256IVEESVTGVHR3Homo sapiens, Mus musculus, Rattus norvegicus
V322CGYGEVGKGCC3Homo sapiens, Mus musculus, Rattus norvegicus
V379TGNKNVVTREH3Homo sapiens, Mus musculus, Rattus norvegicus
Y528FKPNYYRY3Homo sapiens, Mus musculus, Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas